Genus PLC (GNS)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2,555.00p

Buy

2,560.00p

arrow-down-50.00p (-1.92%)

Prices updated at 19 Dec 2025, 18:36 GMT

Prices minimum 15 mins delay

Prices in GBX

Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Iain George Thomas Ferguson CBE

CEO

Mr. Jorgen Kokke

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

3,300

Head office

Matrix House

Basingstoke

United Kingdom

RG21 4FF

+44 1256347100

charlesr@buchanan.uk.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Lesley Mary Samuel Knox OBE Non-Executive Director, Senior Independent Director; Workforce Engagement Director	-
Mr. Iain George Thomas Ferguson CBE Non-Executive Director, Chairman	-
Mr. Andy Russell Executive Director, Chief Financial Officer	-
Mr. Jorgen Kokke Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	2,014,385
Capital Research and Management Company	1,927,424
Jupiter Unit Trust Managers Ltd	1,629,275
European Opportunities Trust	1,629,275
T. Rowe Price	1,543,798

Director dealings

Date chevron-l-regular chevron-r-regular	Action
25 Sep 2025	Exercise of Option
25 Sep 2025	Sale of Option
10 Sep 2025	Transfer in
10 Sep 2025	Transfer in
10 Sep 2025	Transfer in
28 Feb 2025	Exercise of Option
28 Feb 2025	Sale of Option

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.